Business · 21/10/2004
NIH Seeks Exclusive License for Human Parvovirus B19 Vaccine
The National Institutes of Health is considering granting a worldwide exclusive license to practice certain inventions related to a Human Parvovirus B19 vaccine, including patents held by Viral Antigens, Inc.